Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Dickinson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Endocrinology|January 17, 2013
The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathyAnna L Mitchell, Earn H Gan, Margaret Morris, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathyBijay Vaidya, Brian K Shenton, Susan Stamp, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathyA Jane Dickinson, Bijay Vaidya, Margaret Miller, et al.
Clinical Medicine (London, England)|April 1, 2015
Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathwaysPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2014
Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologistsAnna L Mitchell, Linda Goss, Lemonia Mathiopoulou, et al.
The British Journal of Ophthalmology|October 13, 2006
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) surveyDavid McKeag, Carol Lane, John H Lazarus, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2015
Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public InvolvementPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
European Journal of Endocrinology|May 2, 2003
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experienceMark F Prummel, Annemieke Bakker, Wilmar M Wiersinga, et al.
The British Journal of Ophthalmology|May 9, 2015
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012Petros Perros, Miloš Žarković, Claudio Azzolini, et al.
BMJ (Clinical Research Ed.)|March 22, 2013
Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulationsJacky Davis, Ian Banks, David Wrigley, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Endocrinology|January 17, 2013
The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathyAnna L Mitchell, Earn H Gan, Margaret Morris, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathyBijay Vaidya, Brian K Shenton, Susan Stamp, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathyA Jane Dickinson, Bijay Vaidya, Margaret Miller, et al.
Clinical Medicine (London, England)|April 1, 2015
Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathwaysPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2014
Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologistsAnna L Mitchell, Linda Goss, Lemonia Mathiopoulou, et al.
The British Journal of Ophthalmology|October 13, 2006
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) surveyDavid McKeag, Carol Lane, John H Lazarus, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2015
Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public InvolvementPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
European Journal of Endocrinology|May 2, 2003
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experienceMark F Prummel, Annemieke Bakker, Wilmar M Wiersinga, et al.
The British Journal of Ophthalmology|May 9, 2015
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012Petros Perros, Miloš Žarković, Claudio Azzolini, et al.
BMJ (Clinical Research Ed.)|March 22, 2013
Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulationsJacky Davis, Ian Banks, David Wrigley, et al.
Pageof 2